People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| INVO Bioscience, Inc. | — | Biotech | Seed | $7.8M | $29.2M | 2023 |
Barbara Ryan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barbara Ryan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Campbell | 1 | 6 |
| Matthew Szot | 1 | 4 |
| MICHAEL J. CAMPBELL | 1 | 4 |
| Trent Davis | 1 | 4 |
| Steven Shum | 1 | 3 |
| Rebecca Messina | 1 | 3 |
| Andrea Goren | 1 | 2 |
| Kathleen T. Karloff | 1 | 1 |
| Robert J. Bowdring | 1 | 1 |
| Jeffrey Segal | 1 | 1 |
| Debra T. Hoopes | 1 | 1 |
| Kevin Doody | 1 | 1 |
| Claude J. Ranoux | 1 | 1 |
| Kathleen J. Karloff | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.